https://www.selleckchem.com/pr....oducts/Vorinostat-sa
ere alcohol or substance use disorder, and active suicidal or homicidal ideation. Ethics approval was obtained in January 2019, and recruitment of participants began in June 2019. Recruitment has been conducted via social media, web-based communities, and physician referrals. To date, 52 participants have been recruited to the e-CBT group, and 48 patients have been recruited to the in-person CBT group. Data collection is expected to be completed by March 2021, and analyses are expected to be completed by June 2021, as linear reg